The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrent glioblastoma (GBM).
 
Roy E. Strowd
Consulting or Advisory Role - Innocrin Pharma; Monteris Medical
Research Funding - American Academy of Neurology (AAN); Conquer Cancer Foundation; Musella Foundation; Southeastern Brain Tumor Foundation
 
Benjamin M. Ellingson
Consulting or Advisory Role - Agios; Bristol-Myers Squibb; Imaging Endpoints; Medicenna; MedQIA; Nativis; Northwest Biotherapeutics; Novogen; Omniox; Roche/Genentech; Siemens; Tocagen
Research Funding - Agios; Roche/Genentech; Siemens
Travel, Accommodations, Expenses - Nativis; Omniox; Siemens
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Deciphera; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; KIYATEC; Lilly; Puma Biotechnology; Taiho Pharmaceutical; Tocagen; Vascular Biogenics; VBI Vaccines; ZIOPHARM Oncology
Speakers' Bureau - Merck; Prime Oncology
Research Funding - Abbvie (Inst); Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Beigene (Inst); Genentech/Roche (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Vascular Biogenics (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MimiVax
Honoraria - Elsevier; Prime Education; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; CBT Pharmaceuticals; Flatiron Health; Kadmon; Karyopharm Therapeutics; Monteris Medical; Varian Medical Systems; VBI Vaccines
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst)
 
Anna F. Piotrowski
No Relationships to Disclose
 
Arati Suvas Desai
No Relationships to Disclose
 
Jennifer Leigh Clarke
Consulting or Advisory Role - Agios
Research Funding - Agios (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Agios
 
Frank S. Lieberman
No Relationships to Disclose
 
Serena Desideri
No Relationships to Disclose
 
Louis B. Nabors
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Merck/Schering Plough
Travel, Accommodations, Expenses - Merck/Schering Plough
 
Xiaobu Ye
No Relationships to Disclose
 
Stuart A. Grossman
Stock and Other Ownership Interests - Axxia Pharmaceuticals
Consulting or Advisory Role - Abbvie; Medicenna; Midatech Pharma
Patents, Royalties, Other Intellectual Property - Patent related to a subcutaneous polymeric opioid delivery system have been awarded.